BioSpace News Archive

Press Releases

GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder

January 9, 2026
·
6 min read
Press Releases

Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference

January 9, 2026
·
6 min read
Press Releases

Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook

January 9, 2026
·
11 min read
Press Releases

Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor

January 9, 2026
·
11 min read
Press Releases

AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)

January 9, 2026
·
2 min read
Press Releases

Orca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization

January 9, 2026
·
3 min read
Press Releases

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

January 9, 2026
·
3 min read
Press Releases

Naveris® to Highlight New Publications at the 44th Annual J.P. Morgan Healthcare Conference

January 9, 2026
·
2 min read
Press Releases

MEDIPOST Inc. Announces $140 Million in Funding to Accelerate Late-Stage Clinical Development

January 9, 2026
·
2 min read
Press Releases

Mammoth Biosciences to Present at 44th Annual J.P. Morgan Healthcare Conference

January 9, 2026
·
1 min read